Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer

Quantitative imaging is a promising tool that is gaining wide use across several areas of pathology. Although there has been increasing adoption of morphologic and immunohistochemical analysis, the adoption for evaluation of fluorescence in situ hybridization (FISH) on formalin-fixed, paraffin-embed...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of pathology & laboratory medicine (1976) 2023-12, Vol.147 (12), p.1402-1412
Hauptverfasser:	Wilcock, Diane M, Moore, Kristina H, Rowe, Leslie, Mahlow, Jonathan, Jedrzkiewicz, Jolanta, Cleary, Allison S, Lomo, Lesley, Ruano, Ana L, Gering, Maarika, Bradshaw, Derek, Maughan, Meghan, Tran, Phuong, Burlingame, Jesse, Davis, Richard, Affolter, Kajsa, Albertson, Daniel J, Adelhardt, Parisa, Kim, Jong Take, Coleman, Joshua F, Deftereos, Georgios, Gulbahce, Evin H, Sirohi, Deepika
Format:	Artikel
Sprache:	eng
Schlagworte:	Accuracy Automation Breast cancer Breast carcinoma Classification Diagnosis Diagnostic immunohistochemistry Enumeration Epidermal growth factor ErbB-2 protein FDA approval Fluorescence in situ hybridization Hybridization Image processing Immunohistochemistry Methods Oncology Pathology Stacking
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!